Sort   by:  
 Page size 
UnknownBosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.
Not available
S-EPMC5966023 | biostudies-literature
UnknownBosutinib plus capecitabine for selected advanced solid tumours: results of a phase 1 dose-escalation study.
Not available
S-EPMC4260032 | biostudies-literature
UnknownLong-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors.
Not available
S-EPMC5132035 | biostudies-literature
UnknownBosutinib in combination with the aromatase inhibitor letrozole: a phase II trial in postmenopausal women evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer.
Not available
S-EPMC3983830 | biostudies-literature
UnknownBosutinib in combination with the aromatase inhibitor exemestane: a phase II trial in postmenopausal women with previously treated locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer.
Not available
S-EPMC3983831 | biostudies-literature
UnknownSafety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study.
Not available
S-EPMC6068045 | biostudies-literature
UnknownBosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study.
Not available
S-EPMC7387243 | biostudies-literature
Sort   by:  
 Page size